newsfilter
← Latest News
FDA Approved Drugs·

Approval of Ekterly, Nda #219301 (Type 1 - New Molecular Entity)

Approval Date: 07/03/2025; Drug Name: Ekterly, Nda #219301; Active Ingredients: SEBERTRALSTAT; Company: Kalvista Pharmaceuticals Ltd; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity; Application Number: 219301

Company
KALVISTA PHARMACEUTICALS LTD
Keywords
KALVISTA PHARMACEUTICALS LTD